EUDAMED, the European Database on Medical Devices, is a central part of the EU’s medical device regulatory landscape. This centralized hub houses critical information about medical devices circulating in the EU market, including details about their makers, safety assessments, and compliance records.
For medical device manufacturers (MDMs), understanding EUDAMED is more than a regulatory obligation. It equips manufacturers with the knowledge and tools to manage their products’ lifecycle within the EU, from compliance with the Medical Device Regulation (MDR) and In Vitro Diagnostic Medical Device Regulation (IVDR) to product traceability and post-market surveillance.
What is EUDAMED?
EUDAMED is a comprehensive, centralized digital platform that stores and maintains key information about medical devices circulating in the EU market, supporting the transparency and traceability that regulators, manufacturers, and patients depend on to ensure device safety and compliance.
The full EUDAMED system integrates six modules:
- Actor registration
- Unique device identification (UDI) and device registration
- Notified bodies and certificates
- Clinical investigations and performance studies
- Vigilance and post-market surveillance
- Market surveillance
The database includes data on who made the device, detailed descriptions, and any safety or clinical tests it has gone through. In addition to other functionality, the database includes a module for unique device identification (UDI), which aids in the identification and tracking of medical devices. EUDAMED also contains information on certificates issued by notified bodies, clinical investigations, vigilance reports, and market surveillance.
The Importance of EUDAMED to EU Regulatory Compliance and Patient Safety
EUDAMED is a key element in complying with the EU’s MDR and IVDR. As of May 28, 2026, registering in EUDAMED is a legal requirement for manufacturers, importers, and authorized representatives operating in the EU market.
EUDAMED also plays an important role in upholding patient safety within the European Union. By serving as a centralized hub for information on medical devices, manufacturers, certifications, and post-market activities, EUDAMED helps regulatory bodies monitor the market and ensure that only safe and compliant medical devices reach patients.
EUDAMED’s robust traceability allows for the quick identification and tracking of devices, which enhances responsiveness when addressing safety concerns and supports consistent access to high-quality medical devices across EU member states.
EUDAMED’s Current State
EUDAMED is now in effect. As of May 28, 2026, four of the six modules are mandatory for manufacturers, importers, and authorized representatives. After years of delays, the implementation path was clarified in July 2024 when Regulation (EU) 2024/1860 amended the MDR and IVDR to allow individual modules to become mandatory as each one passed an independent audit, rather than waiting for all six to be complete.
On November 27, 2025, Commission Decision (EU) 2025/2371 confirmed that four modules had passed their audit and met functional specifications, triggering a six-month transition period that ended May 28, 2026. The four mandatory modules are:
- Actor registration
- UDI and device registration
- Notified bodies and certificates
- Market surveillance
For devices already on the market before May 28, 2026, manufacturers have until November 28, 2026 to complete registration in the UDI/device module. Notified bodies have until May 28, 2027 to upload legacy certificate data.
The two remaining modules, Vigilance and Clinical Investigations, are still under development. Both will follow the same pattern: mandatory use begins six months after the Commission publishes a functionality notice in the OJEU. The Commission’s draft roadmap projects full six-module implementation around Q2 2027, though those dates remain subject to change. For the latest status, visit the European Commission’s health website on EUDAMED.
Translation and Localization in the Context of EUDAMED
With EUDAMED now mandatory, the translation requirements attached to it are mandatory too. Manufacturers must ensure that device details, instructions for use (IFUs), labeling, safety information, and compliance documentation are available in the official languages of every EU member state where a device is marketed. For some products, that means translations into up to 24 languages.
The stakes are higher than they were under the previous framework. EUDAMED is a centralized system that regulators, notified bodies, and competent authorities all access. Inconsistencies between labels, IFUs, technical documentation, and database entries are now visible in one place in ways they simply weren’t before. For Class III and implantable devices, Summaries of Safety and Clinical Performance must be translated and published directly through EUDAMED. Field Safety Notices require translation into the official languages of every country where the device is available.
For MDMs, this means their language services partner is now part of their compliance chain. Working with a provider certified to ISO 13485:2016, the quality management standard specific to the medical device industry, means having translation processes that can be audited to the same standard as the rest of the regulatory work.
Benefits for Medical Device Manufacturers
MDMs stand to gain significant advantages by using EUDAMED in their operations. It’s a powerful tool for streamlining regulatory compliance processes, offering a centralized platform where MDMs can register their devices, maintain compliance documentation, and access critical information required by European regulations.
EUDAMED provides a standardized framework for device identification and classification, ensuring MDMs can accurately label and classify their products for distribution across EU member states. The Single Registration Number (SRN) assigned through the Actor module is the gateway to all other EUDAMED activity. Without it, manufacturers cannot register devices, submit certificates, or carry out any other regulatory work in the system. By promoting transparency and harmonization, EUDAMED supports smoother market access, enabling MDMs to expand their reach and offer safe and compliant medical devices to a broader European audience.
Staying Current with EUDAMED
EUDAMED is now a functioning regulatory system with four mandatory modules and two more on the way. For medical device manufacturers selling in EU member states, that means translation and documentation requirements will continue to grow as the system reaches full functionality. Working with a language services partner that understands the regulatory framework is the most direct way to stay ahead of those requirements.
For questions about MDR and IVDR translation requirements, visit info.argosmultilingual.com/mdr-europe and info.argosmultilingual.com/ivdr-europe.
Argos Multilingual
6 min. read
When we first published this post a decade ago, the language business looked a lot different than it does today. Machine translation existed but most programs still ran on human translation, priced by the word, delivered by specialists who knew their subject matter. The per-word rate was a reasonable proxy for what a project would […]
